新研究顯示「瑞德西韋」療效佳 張上淳:目前最有機會的新冠肺炎治療藥物
Yahoo! News,
新冠肺炎(武漢肺炎)疫情延燒,全球專家加緊腳步開發解藥及疫苗。《新英格蘭醫學雜誌》日前發表研究結果指出,藥物「瑞德西韋」對68%重症患者都有改善效果。對此,中央流行疫情指揮中心專家諮詢小組召集人張上淳11日表示,目前看來瑞德西韋的療效都相當不錯,也是現階段大…
新冠肺炎(武漢肺炎)疫情延燒,全球專家加緊腳步開發解藥及疫苗。《新英格蘭醫學雜誌》日前發表研究結果指出,藥物「瑞德西韋」對68%重症患者都有改善效果。對此,中央流行疫情指揮中心專家諮詢小組召集人張上淳11日表示,目前看來瑞德西韋的療效都相當不錯,也是現階段大…
London New data recently revealed that more than two-thirds of severely ill coronavirus patients saw their condition improve…
新型コロナウイルスに感染して重い肺炎になった患者53人に、エボラ出血熱の治療薬として開発された「レムデシビル」を使ったところ、68%で症状が改善したことがわかった。日米などの研究チームが米医学誌ニューイングランド・ジャーナル・オブ・メディシン(NEJM)に発…
新型コロナウイルスに感染して重い肺炎になった患者53人に、エボラ出血熱の治療薬として開発された「レムデシビル」を使ったところ、68%で症状が改善したことがわかった。日米などの研究チームが米医学誌ニューイングランド・ジャーナル・オブ・メディシン(NEJM)に発…
新型コロナウイルスに感染して重い肺炎になった患者53人に、エボラ出血熱の治療薬として開発された「レムデシビル」を使ったところ、68%で症状が改善したことがわかった。日米などの研究チームが米医学誌ニューイングランド・ジャーナル・オブ・メディシン(NEJM)に発…
A pair of new coronavirus treatment reports are offering new insights into experimental drugs being tried to treat Covid-19.
Ελπίδες για βελτίωση της κλινικής κατάστασης ασθενών με κορωνοϊό που νοσηλεύονται σε κρίσιμη κατάσταση, δημιουργεί ένα φάρμακο πο…
A potential coronavirus drug called Remdesivir showed encouraging results in a preliminary study.
Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe complications of COVID-19 who…
LOS ANGELES — The small trial of an experimental antiviral drug positioned as a potential treatment for COVID-19 has shown…
Τι λέει ο Η. Μόσιαλος Την αισιοδοξία του για την αποτελεσματικότητα της ρεμδεσιβίρης στη μάχη κατά του κορονοϊού εκφράζει ο Ηλίας…
Ελπιδοφόρες είναι οι εξελίξεις από το επιστημονικό «μέτωπο» του κορωνοϊού, σύμφωνα με όσα δήλωσε ο καθηγητής Σωτήρης Τσιόδρας.
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
ୱାଶିଂଟନ: ଗତ ଚାରିମାସ ଧରି କୋରୋନା ଭାଇରସ୍ ସାରା ବିଶ୍ୱରେ ଏକ ଘୋର ସଙ୍କଟ ସୃଷ୍ଟି କରିଛି। ଅନେକ ଦେଶର ବୈଜ୍ଞାନିକମାନେ ଏଥିପାଇଁ ଔଷଧ ପ୍ରସ୍ତୁତ କରିବା…
Испытания показали эффективность препарата против лихорадки Эбола для лечения пациентов с тяжелой формой коронавируса.
Gilead Drug Shows Positive Results in Early Testing as Two-thirds of Covid-19 Patients Improve "The majority of patients in…
Nova York, Estados Unidos: droga experimental traz esperanças de tratamento contra coronavírus, mas mais testes ainda são necessá…
36 das 53 pessoas testadas demonstraram melhorarias 18 dias após a administração do produto desenvolvido pela Gilead Sciences.
More than 60% of a group of severely ill COVID-19 patients showed improvement when treated with remdesivir, an antiviral drug…
A preliminary report on COVID-19 patients treated with the experimental drug remdesivir suggests that the antiviral medication…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an…
The small trial of an experimental antiviral drug positioned as a potential treatment for COVID-19 has shown encouraging results…
The experimental drug remdesivir helped patients with severe COVID-19, according to a new study.
The paper's author called the findings "hopeful," but cautioned that it is difficult to interpret the results since they do not…
China / Science Study sponsored by drug’s developer Gilead finds dozens of patients, including some on ventilators, improved…
Two thirds of seriously ill Covid-19 patients saw their condition improve after receiving the experimental drug remdesivir…
Source: United Kingdom – Executive Government
New data recently revealed that more than two-thirds of severely ill coronavirus patients saw their condition improve after…
Infected patients are given Remdesivir, a drug undergoing trials, at a hospital in Wuhan, Hubei province, in February.
April 11, 2020 A study, published in The New England Journal of Medicine*, has investigated the use of remdesivir for patients…
أظهرت تجارب أجراها فريق من العلماء على دواء مخصص لعلاج الإيبولا فاعليته على حالات خطرة لمرضى فيروس كورونا المستجد المسبب لمرض (كو…
Περίπου τα δύο τρίτα των ασθενών με σοβαρή λοίμωξη Covid-19 εμφάνισαν βελτίωση της κατάστασης τους μετά τη θεραπεία τους επί δέκα…
Περίπου τα δύο τρίτα των ασθενών με σοβαρή λοίμωξη κορωνοϊού Covid-19 εμφάνισαν βελτίωση της κατάστασης τους μετά τη θεραπεία του…
《新英格蘭醫學》雜誌上昨天發布瑞德西韋(Remdesivir)臨床研究結果,顯示68%的重症患者的病症可得到改善,似乎在這場疫情當中展現曙光,對此張上淳教授今日也在記者會中證實,國內目前也有9位患者正在使用,效果確實不錯,其中一位也使用後順利脫離呼吸器。 該…
《新英格蘭醫學》雜誌上昨天發布瑞德西韋(Remdesivir)臨床研究結果,顯示68%的重症患者的病症可得到改善,似乎在這場疫情當中展現曙光,對此張上淳教授今日也在記者會中證實,國內目前也有9位患者正在使用,效果確實不錯,其中一位也使用後順利脫離呼吸器。 該…
By Deena Beasley (Reuters) – More than two-thirds of seriously ill COVID-19 patients saw improvement in their condition after…
The coronavirus death toll in the U.S. has climbed to nearly 19,000 while the total number of cases surpassed 501,600…
Early research shows that an experimental treatment for the coronavirus may help very sick patients improve their breathing…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
By Deena Beasley More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
By (Reuters) - than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir…
By Deena Beasley (Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment…
By Deena Beasley (Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment…
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an…
WASHINGTON :More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral…
The coronavirus death toll in the U.S. has climbed to nearly 20,000 while the total number of cases surpassed 514,415…
The Gilead Sciences drug has shown promise against other coronaviruses in the past Results from more rigorous studies are…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.
By Deena Beasley April 10 (Reuters) – More than two thirds of seriously ill COVID-19 patients saw improvement in their…
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an…
An experimental treatment for the coronavirus showed promise in an early analysis of the drug as the world scrambles for a cure…
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an…
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an…
A preliminary report on COVID-19 patients treated with the experimental drug remdesivir suggests that the antiviral medication…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
The first glimpse of data for Gilead’s remdesivir show the antiviral improved the symptoms in 68% of patients hospitalized with…
Early research shows that experimental treatment for coronavirus can help very sick patients improve their breathing, although…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
While promising, the drug still needs to undergo rigorous clinical trials to know for sure how effective it is.
Early research shows that an experimental treatment for the coronavirus may help very sick patients improve their breathing…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Credit: Gilead Gilead's CMO Merdad Parsey Merdad Parsey joined Gilead Sciences as chief medical officer in November 2019.
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
Gilead Sciences is reporting some preliminary results from the use of its antiviral drug remdesivir in treating patients with…
‘It looks encouraging’ (Gray News) - More than half of a group of severely ill coronavirus patients improved after receiving an…
(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, doctors…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, doctors…